X-Ceptor Therapeutics - Ownership and Business Overview

Life ScienceCompany

X-Ceptor Therapeutics Ownership

Who owns X-Ceptor Therapeutics?

X-Ceptor Therapeutics is owned by Exelixis. It was acquired on January 14, 2005.

X-Ceptor Therapeutics Business Overview

Where is X-Ceptor Therapeutics headquartered?

X-Ceptor Therapeutics is headquartered in San Diego, California.

What sector is X-Ceptor Therapeutics in?

X-Ceptor Therapeutics is a life science company.

When was X-Ceptor Therapeutics founded?

X-Ceptor Therapeutics was founded in 1999.

Life Science M&A Summary in 2005

Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.

Subscribe to Mergr to view all 78 acquisitions of life science companies in 2005, including 18 acquisitions by private equity firms, and 60 by strategics.

X-Ceptor Therapeutics, Inc.

4757 Nexus Centre Drive Suite 200,
San Diego, California 92121
United States,
(858) 458-4500

X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for X-Ceptor Therapeutics

Life Science Companies